The dietary protein, IGF-I, skeletal health axis

被引:42
|
作者
Bonjour, Jean-Philippe [1 ,2 ]
机构
[1] Univ Hosp Geneva, Div Bone Dis, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland
[2] Fac Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland
关键词
anorexia nervosa; bone acquisition; dietary protein; elderly; fragility fracture; IGF-I; osteoporosis; postmenopausal women;
D O I
10.1515/hmbci-2016-0003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dietary protein represents an important nutrient for bone health and thereby for the prevention of osteoporosis. Besides its role as a brick provider for building the organic matrix of skeletal tissues, dietary protein stimulates the production of the anabolic bone trophic factor IGF-I (insulin-like growth factor I). The liver is the main source of circulating IGF-I. During growth, protein undernutrition results in reduced bone mass and strength. Genetic defect impairing the production of IGF-I markedly reduces bone development in both length and width. The serum level of IGF-I markedly increases and then decreases during pubertal maturation in parallel with the change in bone growth and standing height velocity. The impact of physical activity on bone structure and strength is enhanced by increased dietary protein consumption. This synergism between these two important environmental factors can be observed in prepubertal boys, thus modifying the genetically determined bone growth trajectory. In anorexia nervosa, IGF-I is low as well as bone mineral mass. In selective protein undernutrition, there is a resistance to the exogenous bone anabolic effect of IGF-I. A series of animal experiments and human clinical trials underscore the positive effect of increased dietary intake of protein on calcium-phosphate economy and bone balance. On the contrary, the dietary protein-induced acidosis hypothesis of osteoporosis is not supported by several experimental and clinical studies. There is a direct effect of amino acids on the local production of IGF-I by osteoblastic cells. IGF-I is likely the main mediator of the positive effect of parathyroid hormone (PTH) on bone formation, thus explaining the reduction in fragility fractures as observed in PTH-treated postmenopausal women. In elderly women and men, relatively high protein intake protects against spinal and femoral bone loss. In hip fracture patients, isocaloric correction of the relatively low protein intake results in: increased IGF-I serum level, significant attenuation of postsurgical bone loss, improved muscle strength, better recovery, and shortened hospital stay. Thus, dietary protein contributes to bone health from early childhood to old age. An adequate intake of protein should be recommended in the prevention and treatment of osteoporosis.
引用
收藏
页码:39 / 53
页数:15
相关论文
共 50 条
  • [21] Effects of Insufficient Levels of Dietary Protein on IGF-I and IGFBPs in Young Chickens
    Nagao, Kenji
    Hiramatsu, Kohzy
    Tsukada, Akira
    Kita, Kazumi
    JOURNAL OF POULTRY SCIENCE, 2010, 47 (03): : 236 - 239
  • [22] ROLE OF GI-I AND IGF-I IN THE REGULATION OF IGF-I, IGF-I RECEPTOR AND IGF BINDING-PROTEIN GENE-EXPRESSION IN THE RAT SPLEEN
    DOMENE, HM
    MEIDAN, R
    YAKAR, S
    SHENORR, Z
    CASSORLA, F
    ROBERTS, CT
    LEROITH, D
    REGULATORY PEPTIDES, 1994, 52 (03) : 215 - 226
  • [23] HETEROGENEITY OF IGF-I, IGF-I RECEPTOR AND IGF BINDING-PROTEIN GENE-EXPRESSION IN KIDNEY
    RABKIN, R
    BRODY, M
    LU, L
    CHAN, C
    GILLETT, NA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 793 - 793
  • [24] THE INTRARENAL IGF-I AXIS IN COMPENSATORY RENAL GROWTH
    FERVENZA, F
    TSAO, T
    HSU, F
    RABKIN, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 691 - 691
  • [25] THE INTRARENAL IGF-I AXIS IN DIABETIC RENAL HYPERTROPHY
    FERVENZA, F
    TSAO, T
    HOFFMAN, AR
    VU, T
    RABKIN, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 766 - 766
  • [26] GH/IGF-I axis in severe systemic disorders
    De Feo, P
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (06) : 491 - 492
  • [27] The growth hormone IGF-I axis in dilated cardiomyopathy
    Jenkins, RC
    Ross, RJM
    CLINICAL ENDOCRINOLOGY, 1999, 50 (04) : 415 - 416
  • [28] Axis GH/IGF-I, chronic disease and growth
    不详
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (1-2): : 40 - 40
  • [29] Skeletal effects of growth hormone and IGF-I in adults
    Robert Marcus
    Endocrine, 1997, 7 : 53 - 55
  • [30] THE EFFECT OF IGF-I ON SKELETAL TURNOVER IN POSTMENOPAUSAL WOMEN
    SHAPIRO, JR
    RACHIS, R
    BELLANTONI, M
    HARMAN, SM
    BLACKMAN, MR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S327 - S327